Back to Search Start Over

Electrocardiographic left atrial abnormality and silent vascular brain injury: The Northern Manhattan Study.

Authors :
Hunter MD
Park Moon Y
DeCarli C
Gutierrez J
Wright CB
Di Tullio MR
Sacco RL
Kamel H
Elkind MSV
Source :
PloS one [PLoS One] 2018 Oct 12; Vol. 13 (10), pp. e0203774. Date of Electronic Publication: 2018 Oct 12 (Print Publication: 2018).
Publication Year :
2018

Abstract

Hypothesis: We hypothesized that P wave terminal Force in the V1 lead (PTFV1) would be associated with leukoaraiosis and subclinical infarcts, especially cortical infarcts, in a population-based, multi-ethnic cohort.<br />Methods: PTFV1 was collected manually from baseline electrocardiograms of clinically stroke-free Northern Manhattan Study participants. Investigators read brain MRIs for superficial infarcts, deep infarcts, and white matter hyperintensity volume (WMHV). WMHV was adjusted for head size and log transformed, achieving a normal distribution. Logistic regression models investigated the association of PTFV1 with cortical and with all subclinical infarcts. Linear regression models examined logWMHV. Models were adjusted for demographics and risk factors.<br />Results: Among 1174 participants with PTFV1 measurements, the mean age at MRI was 70 ± 9 years. Participants were 14.4% white, 17.6% black, and 65.8% Hispanic. Mean PTFV1 was 3587.35 ± 2315.62 μV-ms. Of the 170 subclinical infarcts, 40 were cortical. PTFV1 ≥ 5000 μV-ms was associated with WMHV in a fully adjusted model (mean difference in logWMHV 0.15, 95% confidence interval 0.01-0.28). PTFV1 exhibited a trend toward an association with cortical infarcts (unadjusted OR per SD change logPTFV1 1.30, 95% CI 0.94-1.81), but not with all subclinical infarcts.<br />Conclusion: Electrocardiographic evidence of left atrial abnormality was associated with leukoaraiosis.<br />Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following possible competing interests: Dr. Elkind has the following financial disclosures: Boehringer-Ingelheim, Inc.; BMS-Pfizer Alliance; BioTelemetry/Cardionet. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Details

Language :
English
ISSN :
1932-6203
Volume :
13
Issue :
10
Database :
MEDLINE
Journal :
PloS one
Publication Type :
Academic Journal
Accession number :
30312297
Full Text :
https://doi.org/10.1371/journal.pone.0203774